The global orthobiologics market is anticipated to generate revenue of $11575 million by 2027, growing at a CAGR of 5.14% between 2019 and 2027. Improvements in orthobiologics led to the expansion of tissue bone grafts and renewal products that hasten the reducing hospital visits, the bone healing process, and stays. The orthobiologics market is primarily driven by the following factors:

GLOBAL ORTHOBIOLOGICS MARKET FORECAST 2019-2027

Global Orthobiologics Market By End-user (hospitals, Orthopedic Clinics) By Products (demineralized Bone Matrix (dbm), Allograft, Bone Morphogenetic Protein (bmp), Viscosupplementation, Synthetic Bone Substitutes, Stem Cell Therapy, Other Products) By Application (spinal Fusion, Trauma Repair, Reconstructive Surgery, Tendon And Ligament, Other Applications) By Geography.

Request free sample

The global orthobiologics market was valued at $7378.42 billion in 2018 & is estimated to generate net revenue of approximately $11575.02 billion by 2027, growing at a CAGR of 5.14%  Improvements in orthobiologics led to the expansion of tissue bone grafts and renewal products that hasten the reducing hospital visits, the bone healing process, and stays. The orthobiologics market is primarily driven by the following factors:

  • Surging demand for spinal fusion surgeries
  • Increasing geriatric population
  • Increase orthopedic related diseases due to lifestyle choices
  • Technological advancement

Orthobiologics Market

To know more about this report, request a free sample copy

The important drivers that are supporting the growth of the global orthobiologics market are the surging demand for spinal fusion surgeries and the increasing orthopaedic-related diseases occurring due to lifestyle choices. The demand for rapid recovery reduced hospital stay, and better patient outcome resulted in many medical facilities conducting spinal fusion surgery to repair the vertebrae and treat painful conditions of the spine. Aging can intensify complications in the human body, making most people aged 60 years and above susceptible to orthobiologics diseases such as arthritis and spinal deformity.

The applications of orthobiologics market are used extensively for various purposes. Spinal fusion is an operating process used to accurate difficulties with the trivial jaws of the spine (vertebrae). The bone defect is the second most common phenomenon after orthobiologics trauma. Bone grafts are used to fill the voids formed due to bone defects. Knees, hips, and foot and ankle bones are vulnerable to degeneration with aging. Reconstructive surgery is all about mending people and reinstating function. It is executed to overhaul and reshape bodily structures exaggerated by developmental abnormalities, infections, trauma/injuries, birth defects, tumors, and disease. Tendon & ligament is an ortho-biologic surgery that is carried out for repairing the torn-out ligament or muscles. The extensive growth in tendon & ligament repair mechanism drives healthy growth in the orthobiologics market as ortho biologics used to accelerate the recovery and repair procedure of the torn ligament or muscle. Other applications of orthobiologics include the oral and maxillofacial surgery that specializes in the treatment of several defects, injuries and diseases in the jaws, face, neck, head, and the soft and hard tissues of the mouth and maxillofacial region including, face and jaws.

Stringent government policies and post-surgery complications are the major factors hindering the orthobiologics market. Stringent government regulations and policies are estimated to be one of the major factors that are holding back the growth of the market. Healthcare reforms (such as Stark self-referral law and fraud & abuse law) are estimated to have affected the orthobiologics surgeons. While the orthobiologics surgery is a fairly straight forward method, however, there are certain post-surgery complications that are estimated to hinder the growth of the orthobiologics market.

The global orthobiologics market segments include products, applications, and end-users.

Products are sub-segmented into:

  • Bone morphogenetic protein (BMP)
  • Stem cell therapy
  • Synthetic bone substitutes
  • Allograft
  • Demineralized bone matrix (DBM)
  • Viscosupplementation
    • One-injection
    • Three-injection
    • Five-injection
  • Other Product

Applications are sub-segmented into:

  • Spinal Fusion
  • Tendon and ligament
  • Reconstructive Surgery
  • Trauma Repair
  • Other Applications

End-users are segmented into:

  • Hospitals
  • Orthopedic Clinics

This report covers the present market conditions and the growth prospects of the Global orthobiologics market for 2019-2027 and considered the revenue generated through the sales of orthobiologics products as well as applications to calculate the market size by considering 2018 as the base year.

Geographically, the global orthobiologics market has been segmented on the basis of four major regions, which include:

The orthobiologics market in North America is expected to hold the largest share by 2027 possibilities of more awareness about orthobiologics is a driving force for surgeons to switch from automated implants to biological implants. North America orthobiologics market constitutes approx. 43% share. The United States orthobiologics market has the largest share in North America and it’s expected to grow continuously. The Canadian region will also have growth driven by aging population, increasing research investments and an increased number of road accidents.

On the other hand, the Asia-Pacific market is anticipated to the fastest-growing region for the orthobiologics market. China accounts for the largest share of the Asian orthobiologics market. The market in this geographic segment is slated to grow further due to the augmented growth in research, and the growth in the aging population in the country. The market in India and Japan is expected to witness the highest growth owing to the rising geriatric population and the increasing number of road accidents in the country.

The orthobiologics market is segmented based on products which are sub-divided into demineralized bone Matrix (DBM), bone morphogenetic protein (BMP), allograft, synthetic bone substitutes, Viscosupplementation, stem cell therapy, and others and segmented on the basis of end-user which is sub-divided into hospitals and orthopedic clinics.

Demineralized bone matrix is an allograft decalcified to remove collagen, non-collagenous proteins, and other growth factors. Allografts come from donors, people who died in accidents or from sudden illnesses. Bone morphogenetic proteins are a group of growth factors such as cytokines that stimulate bone growth. These proteins, produced through genetic engineering, can help in bone healing. Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Stem cells have gained popularity for bone regeneration in the recent past. The hospital’s segment is one of the prime consumers of ethno biological products. The orthopedic clinics are the place where outpatients suffering from musculoskeletal diseases affecting their joints, muscle, and bone are examined and treated.

The major market players of the global orthobiologics market are:

  • Medtronic Inc.
  • Exatech Inc.
  • Integra Lifesciences Holding Corporation
  • Baxter International Inc.
  • Depuy Inc. (Acquired By Johnson And Johnson)

Company Profiles covers analysis of important players. Medtronic is a medical device company. It was formed in the year 1949 with its headquarters in Dublin, Ireland. Its operative HQs are in Minnesota. Medtronic is one of the world’s major medicinal equipment development corporations. DePuy Synthes Companies (DePuy Synthes or ‘the division’) is a division of the diagnostics (MD&D) and medical device segment of Johnson & Johnson (J&J). The division offers a comprehensive portfolio of orthopedic and neuro products and services.

Key Findings of the global orthobiologics market:

  • Hospitals are the largest revenue generating end user
  • Spinal fusion is the fastest growing application
  • Viscosupplementation holds the largest market share in terms of product
  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP-DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • HOSPITALS ARE THE LARGEST REVENUE GENERATING END-USER
      • SPINAL FUSION IS THE FASTEST GROWING APPLICATION
      • VISCOSUPPLEMENTATION HOLDS THE LARGEST MARKET SHARE IN TERMS OF PRODUCTS
  1. MARKET DYNAMICS
    • MARKET SCOPE & DEFINITION
    • MARKET DRIVERS
      • SURGING DEMAND FOR SPINAL FUSION SURGERIES
      • INCREASING GERIATRIC POPULATION
      • INCREASE ORTHOPAEDIC RELATED DISEASES DUE TO LIFESTYLE CHOICES
      • TECHNOLOGICAL ADVANCEMENT
    • MARKET RESTRAINTS
      • STRINGENT GOVERNMENT POLICIES
      • POST-SURGERY COMPLICATIONS
      • HIGH COST OF ORTHOPEDICS IMPLANTS
    • MARKET OPPORTUNITIES
      • INCREASED UTILIZATION OF BONE REGENERATION TECHNOLOGY
      • GROWING DISPOSABLE INCOME
      • EXPANSION OF COST EFFECTIVE MEDICAL PRODUCTS
      • HUGE MARKET OPPORTUNITIES IN DEVELOPING COUNTRIES
    • MARKET CHALLENGES
      • HIGH COST OF SPINAL FUSION SURGERY
      • POOR PERFORMANCE OF BONE GRAFT SUBSTITUTE
  1. MARKET BY END-USER
    • HOSPITALS
    • ORTHOPEDIC CLINICS
  2. MARKET BY PRODUCTS
    • DEMINERALIZED BONE MATRIX (DBM)
    • ALLOGRAFT
    • BONE MORPHOGENETIC PROTEIN (BMP)
    • VISCOSUPPLEMENTATION
      • ONE-INJECTION
      • THREE-INJECTION
      • FIVE-INJECTION
    • SYNTHETIC BONE SUBSTITUTES
    • STEM CELL THERAPY
    • OTHER PRODUCTS
  3. MARKET BY APPLICATION
    • SPINAL FUSION
    • TRAUMA REPAIR
    • RECONSTRUCTIVE SURGERY
    • TENDON AND LIGAMENT
    • OTHER APPLICATIONS
  4. KEY ANALYTICS
    • PORTER’S FIVE FORCE MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE
      • BARGAINING POWER OF BUYER
      • BARGAINING POWER OF SUPPLIER
      • INTENSITY OF COMPETITIVE RIVALRY
    • PESTEL ANALYSIS
    • PATENT ANALYSIS
    • KEY BUYING CRITERIA
    • VALUE CHAIN ANALYSIS
    • OPPORTUNITY MATRIX
  5. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    • EUROPE
      • THE UNITED KINGDOM
      • FRANCE
      • GERMANY
      • SPAIN
      • ITALY
      • REST OF EUROPE
    • ASIA-PACIFIC
      • INDIA
      • CHINA
      • JAPAN
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF ASIA-PACIFIC
    • REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST AND AFRICA
  1. COMPETITIVE LANDSCAPE
    • MARKET SHARE ANALYSIS
    • COMPANY PROFILES
      • AAP IMPLANTATE AG
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
      • ALLOSOURCE
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVE
      • AMEDICA CORPORATION
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • BAXTER INTERNATIONAL INC.
        • MARKET OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • CONMED CORPORATION
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
      • DEPUY INC (ACQUIRED BY JOHNSON AND JOHNSON)
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • EXACTECH INC.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • INTEGRA LIFESCIENCES HOLDING CORPORATION
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • MEDTRONIC INC.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • NUVASIVE INC.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • RTI SURGICAL
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • SANOFI
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • SMITH & NEPHEW PLC
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • STRYKER CORPORATION
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • ZIMMER BIOMET INC.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES

TABLE LIST

TABLE  1       GLOBAL ORTHOBIOLOGICS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  2       OLDER POPULATION BY AGE GROUP ( 1900 TO 2050)

TABLE  3       POST-SURGERY COMPLICATIONS

TABLE  4       GLOBAL ORTHOBIOLOGICS MARKET BY END-USER 2019-2027 ($ MILLION)

TABLE  5       GLOBAL HOSPITALS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  6       GLOBAL ORTHOPEDIC CLINICS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  7       GLOBAL ORTHOBIOLOGICS MARKET BY PRODUCTS 2019-2027 ($ MILLION)

TABLE  8       GLOBAL DEMINERALIZED BONE MATRIX (DBM) MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  9       GLOBAL ALLOGRAFT MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  10     GLOBAL BONE MORPHOGENETIC PROTEIN (BMP) MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  11     GLOBAL VISCOSUPPLEMENTATION MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  12     SINGLE INJECTION IN VISCOSUPPLEMENTATION COST AND DIFFERENT BRAND

TABLE  13     MULTIPLE INJECTIONS IN VISCOSUPPLEMENTATION

TABLE  14     GLOBAL SYNTHETIC BONE SUBSTITUTES MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  15     GLOBAL STEM CELL THERAPY MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  16     GLOBAL OTHER PRODUCTS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  17     GLOBAL ORTHOBIOLOGICS MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE  18     GLOBAL SPINAL FUSION MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  19     GLOBAL TRAUMA REPAIR MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  20     GLOBAL RECONSTRUCTIVE SURGERY MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  21     GLOBAL TENDON AND LIGAMENT MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  22     GLOBAL OTHER APPLICATIONS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  23     GLOBAL ORTHOBIOLOGICS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE  24     NORTH AMERICA ORTHOBIOLOGICS MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE  25     EUROPE ORTHOBIOLOGICS MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE  26     AGE STRUCTURE OF GERMANY 2017

TABLE  27     ASIA-PACIFIC VETERINARY DIAGNOSTIC MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE  28     SPORTS INJURIES CAUSED IN AUSTRALIA BY SPORTS IN 2016

TABLE  29     REST OF THE WORLD ORTHOBIOLOGICS MARKET 2019-2027 (IN $ MILLION)

FIGURES LIST

FIGURE  1     GLOBAL ORTHOBIOLOGICS MARKET 2019-2027 ($ MILLION)

FIGURE  2     INCREASING DEMAND OF MINIMAL INVASIVE TECHNOLOGIES 2010-2025 ($ MILLION)

FIGURE  3     GLOBAL ORTHOBIOLOGICS MARKET SHARE BY END-USER 2018 & 2027 (%)

FIGURE  4     GLOBAL ORTHOBIOLOGICS MARKET BY HOSPITALS 2019-2027 ($ MILLION)

FIGURE  5     GLOBAL ORTHOBIOLOGICS MARKET BY ORTHOPEDIC CLINICS 2019-2027 ($ MILLION)

FIGURE  6     GLOBAL ORTHOBIOLOGICS MARKET SHARE BY PRODUCTS 2018 & 2027 (%)

FIGURE  7     GLOBAL ORTHOBIOLOGICS MARKET BY DEMINERALIZED BONE MATRIX (DBM) 2019-2027 ($ MILLION)

FIGURE  8     GLOBAL ORTHOBIOLOGICS MARKET BY ALLOGRAFT 2019-2027 ($ MILLION)

FIGURE  9     GLOBAL ORTHOBIOLOGICS MARKET BY BONE MORPHOGENETIC PROTEIN (BMP) 2019-2027 ($ MILLION)

FIGURE  10  GLOBAL ORTHOBIOLOGICS MARKET BY VISCOSUPPLEMENTATION 2019-2027 ($ MILLION)

FIGURE  11  GLOBAL VISCOSUPPLEMENTATION MARKET BY ONE-INJECTION 2019-2027 ($ MILLION)

FIGURE  12  GLOBAL VISCOSUPPLEMENTATION MARKET BY THREE-INJECTION 2019-2027 ($ MILLION)

FIGURE  13  GLOBAL VISCOSUPPLEMENTATION MARKET BY FIVE-INJECTION 2019-2027 ($ MILLION)

FIGURE  14  GLOBAL ORTHOBIOLOGICS MARKET BY SYNTHETIC BONE SUBSTITUTES 2019-2027 ($ MILLION)

FIGURE  15  GLOBAL ORTHOBIOLOGICS MARKET BY STEM CELL THERAPY 2019-2027 ($ MILLION)

FIGURE  16  GLOBAL ORTHOBIOLOGICS MARKET BY OTHER PRODUCTS 2019-2027 ($ MILLION)

FIGURE  17  GLOBAL ORTHOBIOLOGICS MARKET SHARE BY APPLICATION 2018 & 2027 (%)

FIGURE  18  GLOBAL ORTHOBIOLOGICS MARKET BY SPINAL FUSION 2019-2027 ($ MILLION)

FIGURE  19  GLOBAL ORTHOBIOLOGICS MARKET BY TRAUMA REPAIR 2019-2027 ($ MILLION)

FIGURE  20  GLOBAL ORTHOBIOLOGICS MARKET BY RECONSTRUCTIVE SURGERY 2019-2027 ($ MILLION)

FIGURE  21  GLOBAL ORTHOBIOLOGICS MARKET BY TENDON AND LIGAMENT 2019-2027 ($ MILLION)

FIGURE  22  GLOBAL ORTHOBIOLOGICS MARKET BY OTHER APPLICATIONS 2019-2027 ($ MILLION)

FIGURE  23  PORTER’S FIVE FORCE MODEL

FIGURE  24  GLOBAL ORTHOBIOLOGICS MARKET REGIONAL OUTLOOK 2018 & 2027 (%)

FIGURE  25  HEALTHCARE EXPENDITURE IN THE UNITED STATES  2014 & 2025 (% OF GDP)

FIGURE  26  THE UNITED STATES ORTHOBIOLOGICS MARKET 2019-2027 ($ MILLION)

FIGURE  27  CANADA ORTHOBIOLOGICS MARKET 2019-2027 ($ MILLION)

FIGURE  28  EUROPE ORTHOBIOLOGICS MARKET BY COUNTRY 2018  & 2027

FIGURE  29  THE UNITED KINGDOM ORTHOBIOLOGICS MARKET 2019-2027 ($ MILLION)

FIGURE  30  FRANCE ORTHOBIOLOGICS MARKET 2019-2027 ($ MILLION)

FIGURE  31  GERMANY ORTHOBIOLOGICS MARKET 2019-2027 ($ MILLION)

FIGURE  32  SPAIN ORTHOBIOLOGICS MARKET, 2019-2027 ($ MILLION)

FIGURE  33  ITALY ORTHOBIOLOGICS MARKET, 2019-2027 ($ MILLION)

FIGURE  34  REST OF EUROPE ORTHOBIOLOGICS MARKET 2019-2027 ($ MILLION)

FIGURE  35  ASIA PACIFIC ORTHOBIOLOGICS MARKET BY COUNTRY 2018  & 2027

FIGURE  36  GROWING AGING POPULATION RATE 2010 AND 2050

FIGURE  37  INDIA VETERINARY DIAGNOSTIC MARKET 2019-2027 ($ MILLION)

FIGURE  38  CHINA VETERINARY DIAGNOSTIC MARKET 2019-2027 ($ MILLION)

FIGURE  39  JAPAN VETERINARY DIAGNOSTIC MARKET 2019-2027 ($ MILLION)

FIGURE  40  AUSTRALIA VETERINARY DIAGNOSTIC MARKET 2019-2027 ($ MILLION)

FIGURE  41  SOUTH KOREA VETERINARY DIAGNOSTIC MARKET 2019-2027 ($ MILLION)

FIGURE  42  REST OF ASIA-PACIFIC VETERINARY DIAGNOSTIC MARKET 2019-2027 ($ MILLION)

FIGURE  43  LATIN AMERICA ORTHOBIOLOGICS MARKET 2019-2027 (IN $ MILLION)

FIGURE  44  MIDDLE EAST AND AFRICA ORTHOBIOLOGICS MARKET 2019-2027 (IN $ MILLION)

FIGURE  45  ORTHOBIOLOGICS COMPANY  MARKET SHARE 2018 (% )

  1. MARKET BY END-USER
    • HOSPITALS
    • ORTHOPEDIC CLINICS
  2. MARKET BY PRODUCTS
    • DEMINERALIZED BONE MATRIX (DBM)
    • ALLOGRAFT
    • BONE MORPHOGENETIC PROTEIN (BMP)
    • VISCOSUPPLEMENTATION
      • ONE-INJECTION
      • THREE-INJECTION
      • FIVE-INJECTION
    • SYNTHETIC BONE SUBSTITUTES
    • STEM CELL THERAPY
    • OTHER PRODUCTS
  3. MARKET BY APPLICATION
    • SPINAL FUSION
    • TRAUMA REPAIR
    • RECONSTRUCTIVE SURGERY
    • TENDON AND LIGAMENT
    • OTHER APPLICATIONS
  4. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    • EUROPE
      • THE UNITED KINGDOM
      • FRANCE
      • GERMANY
      • SPAIN
      • ITALY
      • REST OF EUROPE
    • ASIA-PACIFIC
      • INDIA
      • CHINA
      • JAPAN
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF ASIA-PACIFIC
    • REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST AND AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    Choose License Type